This analysis in RR MCL shows CAR T-cell therapy (brexucabtagene) yields higher complete responses vs bispecific antibodies; durability remains unclear.
|Articles|January 1, 1997
Supplements and Featured Publications
- Managing Hypercholesterolemia and Coronary Heart Disease
- Volume 3
- Issue 1 Suppl
Introduction
Advertisement
Articles in this issue
almost 30 years ago
MCO Decisions and Solutionsalmost 30 years ago
The Importance of Lipid Lowering and Other Risk Reduction Therapiesalmost 30 years ago
Matching Risks to Interventions: When to Treat, How to Treatalmost 30 years ago
CME Quizalmost 30 years ago
Bibliographyalmost 30 years ago
Participantsalmost 30 years ago
Goals and Objectivesalmost 30 years ago
Clinical Study Outcomes and the Benefits of Treating Hypercholesterolemiaalmost 30 years ago
Goals for Patient Treatmentalmost 30 years ago
Pharmacoeconomics: The Cost Effectiveness of Lipid ManagementAdvertisement
Related to this article
Meta-analysis finds oral JAK inhibitors like baricitinib and ritlecitinib drive strong alopecia areata hair regrowth, improving SALT scores with manageable safety.
Follitropin delta yields cumulative ongoing pregnancy in 64.0% of patients under 35 and 43.9% of those 35 to 42 in 2 placebo-controlled IVF trials.
The Ambulatory Specialty Model aims to reduce chronic disease costs by mandating specialist participation and tying payments to quality and cost, while posing nationwide risk challenges.
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches.
Rosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
2
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV
3
Rusfertide Keeps Working Where Hydroxyurea Fades: Andrew Kuykendall, MD
4
New Mechanism of DME Treatment Highlights Clinical Trial Updates
5